Research Article

The Serum Expression of Selected miRNAs in Pulmonary Sarcoidosis with/without Löfgren’s Syndrome

Table 2

Bronchoalveolar cellular profile in our patients with pulmonary sarcoidosis.

SarcoidosisWith LS (CXR 1) Without LS (CXR 3)

Cellular profileMean (min–max)Mean (min–max)
Total cell count 106/mL0.85 (0.40–1.35)0.72 (0.10–1.40)
Macrophage absolute count0.66 (0.28–1.02)0.58 (0.09–1.40)
Macrophage relative count (%)77.31 (57.00–91.10)76.67 (43.00–90.70)
Lymphocytes absolute count0.18 (0.06–0.45)0.14 (0.01–0.33)
Lymphocytes relative count (%)20.58 (8.60–41.00)20.08 (8.00–46.00)
Neutrophils absolute count0.01 (0.00–0.04)0.02 (0.00–0.05)
Neutrophils relative count (%)1.68 (0.00–8.00)2.27 (0.00–6.00)
Eosinophils absolute count0.00 (0.00–0.01)0.00 (0.00–0.02)
Eosinophils relative count (%)0.43 (0.00–2.00)0.99 (0.00–7.00)
CD3+ absolute count0.56 (0.00–1.13)0.35 (0.00–1.06)
CD3+ relative count (%)84.62 (58.00–94.00)75.00 (36.00–96.00)
CD4+ absolute count0.26 (0.00–0.79)0.15 (0.00–0.67)
CD4+ relative count (%)71.69 (35.00–90.00)55.58 (29.00–89.00)
CD8+ absolute count0.06 (0.00–0.26)0.04 (0.00–0.19)
CD8+ relative count (%)13.08 (3.00–31.00)21.00 (4.00–53.00)
CD19+ absolute count0.00 (0.00–0.01)0.00 (0.00–0.02)
CD19+ relative count (%)0.54 (0.00–2.00)1.08 (0.00–2.00)
CD4+/CD8+9.45 (1.13–30.00)5.34 (0.55–22.25)

CXR, chest X-ray; LS, Löfgren’s syndrome.